Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy is a research paper published in Science Advances (2021). On theSindex it has a DataRank of 0. It has been cited 49 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA198999
National Natural Science Foundation of China
Grant: 51773176
NCI NIH HHS
Grant: U54 CA198999
National Institutes of Health
Grant: 5U54CA198999-04
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 3 of Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment
Additional file 3 of Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment
Additional file 1 of Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment
Additional file 1 of Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment
Additional file 2 of Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment
Additional file 2 of Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment